Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 8410

1.

[Antipsychotics in bipolar disorders].

Vacheron-Trystram MN, Braitman A, Cheref S, Auffray L.

Encephale. 2004 Sep-Oct;30(5):417-24. Review. French.

PMID:
15627046
2.

A rapid and systematic review and economic evaluation of the clinical and cost-effectiveness of newer drugs for treatment of mania associated with bipolar affective disorder.

Bridle C, Palmer S, Bagnall AM, Darba J, Duffy S, Sculpher M, Riemsma R.

Health Technol Assess. 2004 May;8(19):iii-iv, 1-187. Review.

3.

Valproic acid, valproate and divalproex in the maintenance treatment of bipolar disorder.

Cipriani A, Reid K, Young AH, Macritchie K, Geddes J.

Cochrane Database Syst Rev. 2013 Oct 17;(10):CD003196. doi: 10.1002/14651858.CD003196.pub2. Review.

PMID:
24132760
4.

A systematic review and economic model of the clinical effectiveness and cost-effectiveness of interventions for preventing relapse in people with bipolar disorder.

Soares-Weiser K, Bravo Vergel Y, Beynon S, Dunn G, Barbieri M, Duffy S, Geddes J, Gilbody S, Palmer S, Woolacott N.

Health Technol Assess. 2007 Oct;11(39):iii-iv, ix-206. Review.

5.

Using antipsychotic agents in older patients.

Alexopoulos GS, Streim J, Carpenter D, Docherty JP; Expert Consensus Panel for Using Antipsychotic Drugs in Older Patients.

J Clin Psychiatry. 2004;65 Suppl 2:5-99; discussion 100-102; quiz 103-4. Review.

6.

Aripiprazole alone or in combination for acute mania.

Brown R, Taylor MJ, Geddes J.

Cochrane Database Syst Rev. 2013 Dec 17;(12):CD005000. doi: 10.1002/14651858.CD005000.pub2. Review.

PMID:
24346956
7.

[Prescription of olanzapine in children and adolescent psychiatric patients].

Frémaux T, Reymann JM, Chevreuil C, Bentué-Ferrer D.

Encephale. 2007 Mar-Apr;33(2):188-96. Review. French.

PMID:
17675914
8.

Summary of the comparative effectiveness review on off-label use of atypical antipsychotics.

Maher AR, Theodore G.

J Manag Care Pharm. 2012 Jun;18(5 Suppl B):S1-20. Review.

PMID:
22784311
9.

A naturalistic comparison of clozapine, risperidone, and olanzapine in the treatment of bipolar disorder.

Guille C, Sachs GS, Ghaemi SN.

J Clin Psychiatry. 2000 Sep;61(9):638-42.

PMID:
11030483
10.

[Cost-effectiveness analysis of schizophrenic patient care settings: impact of an atypical antipsychotic under long-acting injection formulation].

Llorca PM, Miadi-Fargier H, Lançon C, Jasso Mosqueda G, Casadebaig F, Philippe A, Guillon P, Mehnert A, Omnès LF, Chicoye A, Durand-Zaleski I.

Encephale. 2005 Mar-Apr;31(2):235-46. Review. French.

PMID:
15959450
11.

Drug Class Review: Atypical Antipsychotic Drugs: Final Update 3 Report [Internet].

McDonagh M, Peterson K, Carson S, Fu R, Thakurta S.

Portland (OR): Oregon Health & Science University; 2010 Jul.

12.

Olanzapine/fluoxetine combination for the treatment of mixed depression in bipolar I disorder: a post hoc analysis.

Benazzi F, Berk M, Frye MA, Wang W, Barraco A, Tohen M.

J Clin Psychiatry. 2009 Oct;70(10):1424-31. doi: 10.4088/JCP.08m04772gre.

PMID:
19906346
13.

Advantages and disadvantages of combination treatment with antipsychotics ECNP Consensus Meeting, March 2008, Nice.

Goodwin G, Fleischhacker W, Arango C, Baumann P, Davidson M, de Hert M, Falkai P, Kapur S, Leucht S, Licht R, Naber D, O'Keane V, Papakostas G, Vieta E, Zohar J.

Eur Neuropsychopharmacol. 2009 Jul;19(7):520-32. doi: 10.1016/j.euroneuro.2009.04.003. Epub 2009 May 2.

PMID:
19411165
14.

Valproate for acute mood episodes in bipolar disorder.

Macritchie K, Geddes JR, Scott J, Haslam D, de Lima M, Goodwin G.

Cochrane Database Syst Rev. 2003;(1):CD004052. Review.

PMID:
12535506
15.

A 6-month, double-blind, maintenance trial of lithium monotherapy versus the combination of lithium and divalproex for rapid-cycling bipolar disorder and Co-occurring substance abuse or dependence.

Kemp DE, Gao K, Ganocy SJ, Elhaj O, Bilali SR, Conroy C, Findling RL, Calabrese JR.

J Clin Psychiatry. 2009 Jan;70(1):113-21. Epub 2008 Dec 30.

16.

Rational polypharmacy in the bipolar affective disorders.

Post RM, Ketter TA, Pazzaglia PJ, Denicoff K, George MS, Callahan A, Leverich G, Frye M.

Epilepsy Res Suppl. 1996;11:153-80. Review.

PMID:
9294735
17.

Bipolar depression: the role of atypical antipsychotics.

Post RM, Calabrese JR.

Expert Rev Neurother. 2004 Nov;4(6 Suppl 2):S27-33.

PMID:
16279863
18.

Optimal duration of risperidone or olanzapine adjunctive therapy to mood stabilizer following remission of a manic episode: A CANMAT randomized double-blind trial.

Yatham LN, Beaulieu S, Schaffer A, Kauer-Sant'Anna M, Kapczinski F, Lafer B, Sharma V, Parikh SV, Daigneault A, Qian H, Bond DJ, Silverstone PH, Walji N, Milev R, Baruch P, da Cunha A, Quevedo J, Dias R, Kunz M, Young LT, Lam RW, Wong H.

Mol Psychiatry. 2016 Aug;21(8):1050-6. doi: 10.1038/mp.2015.158. Epub 2015 Oct 13.

19.

Valproic acid, valproate and divalproex in the maintenance treatment of bipolar disorder.

Macritchie KA, Geddes JR, Scott J, Haslam DR, Goodwin GM.

Cochrane Database Syst Rev. 2001;(3):CD003196. Review. Update in: Cochrane Database Syst Rev. 2013;10:CD003196.

PMID:
11687047
20.

Olanzapine: a review of its use in the treatment of bipolar I disorder.

Bhana N, Perry CM.

CNS Drugs. 2001;15(11):871-904. Review.

PMID:
11700151

Supplemental Content

Support Center